OBJECTIVE: The aim of the present investigation was to examine the association between body mass index (BMI) and peritonitis rates among incident peritoneal dialysis (PD) patients in a large cohort with long-term follow-up. DESIGN: Retrospective observational cohort study of the Australian and New Zealand PD patient population. SETTING: Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry. PARTICIPANTS: The study included all incident adult patients (n = 10 709) who received PD in Australia and New Zealand in the 12-year period between 1 April 1991 and 31 March 2003. Patients were classified as obese (BMI > or = 30 kg/m2), overweight (BMI 25.0 - 29.9 kg/m2), normal weight (20 - 24.9 kg/m2), or underweight (< 20 kg/m2). MAIN MEASUREMENTS: Time to first peritonitis and episodes of peritonitis per patient-year were recorded over the 12-year period. RESULTS: Higher BMI was associated with a shorter time to first peritonitis episode, independent of other risk factors [hazard ratio 1.08 for each 5-kg/m2 increase in BMI, 95% confidence interval (CI) 1.04 - 1.12, p < 0.001]. When peritonitis outcomes were analyzed as episodes of peritonitis per patient-year, these rates were significantly higher among patients with higher BMI: underweight 0.69 episodes/year (95% CI 0.66 - 0.73), normal weight 0.79 (95% CI 0.77 - 0.81), overweight 0.88 (95% CI 0.85 - 0.90), obese 1.06 (95% CI 1.02 - 1.09). Coronary artery disease and chronic lung disease were associated with both shorter time to first peritonitis and higher peritonitis rates, independently of these other factors. There was also a "vintage effect," with lower peritonitis rates seen among people who commenced dialysis in more recent years. CONCLUSIONS: Higher BMI at the commencement of renal replacement therapy is a significant risk factor for peritonitis. The mechanisms for this remain undefined.

This article has been cited by other articles:

				S. S. Elshafie, M. Asim, A. Ashour, A. H. Elhiday, T. Mohsen, and S. Doiphode CAMPYLOBACTER PERITONITIS COMPLICATING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS: REPORT OF THREE CASES AND REVIEW OF THE LITERATURE Perit. Dial. Int., January 1, 2010; 30(1): 99 - 104. [Abstract] [Full Text] [PDF]

				S. J. Nessim, J. M. Bargman, P. C. Austin, R. Nisenbaum, and S. V. Jassal Predictors of Peritonitis in Patients on Peritoneal Dialysis: Results of a Large, Prospective Canadian Database Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1195 - 1200. [Abstract] [Full Text] [PDF]

				F. F. Ersoy IMPROVING TECHNIQUE SURVIVAL IN PERITONEAL DIALYSIS: WHAT IS MODIFIABLE? Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S74 - S77. [Abstract] [Full Text] [PDF]

				S.-H. Park and B. Lindholm DEFINITION OF METABOLIC SYNDROME IN PERITONEAL DIALYSIS Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S137 - S144. [Abstract] [Full Text] [PDF]

				P. K.-T. Li, B. C.-H. Kwan, C. C. Szeto, and G. T.-C. Ko Metabolic syndrome in peritoneal dialysis patients NDT Plus, August 1, 2008; 1(4): 206 - 214. [Abstract] [Full Text] [PDF]

				K. M. Chow, C. C. Szeto, M. C. Law, J. S. Fun Fung, and P. Kam-Tao Li Influence of Peritoneal Dialysis Training Nurses' Experience on Peritonitis Rates Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 647 - 652. [Abstract] [Full Text] [PDF]

				D. W. Johnson WHAT IS THE OPTIMAL FAT MASS IN PERITONEAL DIALYSIS PATIENTS? Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S250 - S254. [Abstract] [Full Text] [PDF]

				A. E. Stinghen, P. Barretti, and R. Pecoits-Filho FACTORS CONTRIBUTING TO THE DIFFERENCES IN PERITONITIS RATES BETWEEN CENTERS AND REGIONS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S281 - S285. [Abstract] [Full Text] [PDF]

				J. K. Inrig, J. L. Sun, Q. Yang, L. P. Briley, and L. A. Szczech Mortality by Dialysis Modality among Patients Who Have End-Stage Renal Disease and Are Awaiting Renal Transplantation Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 774 - 779. [Abstract] [Full Text] [PDF]

Copyright © 2004 by Multimed Inc.